📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Validity of the UK early access to medicines scheme criteria for Remdesivir use in patients with COVID-19 disease (2020)

First Author: Daunt A

Attributed to: Centre for Global Infectious Disease Analysis, Imperial College London (GIDA) - COVID-19 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.jinf.2020.06.049

PubMed Identifier: 32579980

Publication URI: http://europepmc.org/abstract/MED/32579980

Type: Journal Article/Review

Parent Publication: Journal of Infection

Issue: 4

ISSN: 0163-4453